RAPP – rapport therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Rapport Therapeutics (NASDAQ:RAPP) was downgraded by analysts at Wall St
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at Wall Stre
Rapport Therapeutics (NASDAQ:RAPP) was downgraded by analysts at Wall St
Rapport Therapeutics (NASDAQ:RAPP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Form 4 Rapport Therapeutics, For: Feb 18 Filed by: Ceesay Abraham
Form 4 Rapport Therapeutics, For: Feb 17 Filed by: Bredt David
Form SCHEDULE 13G/A Rapport Therapeutics, Filed by: Cormorant Asset Management, LP
Form 4 Rapport Therapeutics, For: Feb 02 Filed by: Sevigny Jeffrey
Form 4 Rapport Therapeutics, For: Feb 02 Filed by: Ceesay Abraham
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.